SARS Matrix

SARS-Associated Coronavirus Matrix Recombinant
Cat. No.
BT4975
Source
Synonyms
Appearance
Purity
SARS Matrix Protein is >95% pure as determined by 10% PAGE (coomassie staining).
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The E.Coli derived 30kDa recombinant protein contains the Matrix protein 182-216 amino acids immunodominant regions.

Product Specs

Introduction
The SARS Coronavirus is characterized by an envelope featuring three key structural proteins: membrane (M), envelope (E), and spike (S). The spike (S) glycoprotein facilitates viral entry into host cells by binding to a cellular receptor and mediating membrane fusion. This crucial role in the virus infection cycle makes the S-protein a primary target for neutralizing antibodies.
Description
This recombinant protein, derived from E. coli, has a molecular weight of 30kDa and encompasses amino acids 182-216 of the Matrix protein, a region known for its immunodominance.
Purity
Analysis by 10% PAGE (coomassie staining) indicates that the purity of the SARS Matrix Protein exceeds 95%.
Formulation
The SARS Matrix Protein is supplied in a buffer solution comprising 50mM Tris-HCl, 60mM NaCl, and 50% glycerol.
Stability
The SARS Matrix protein is shipped at ambient temperature. Upon receipt, it should be stored at -20°C.
Applications
The SARS Matrix antigen serves as a valuable reagent in ELISA and Western blot assays. Its high specificity makes it an excellent choice for detecting SARS.
Purification Method
SARS Matrix protein was purified by proprietary chromatographic technique.
Specificity
SARS Matrix protein is Immunoreactive with sera of SARS-infected individuals.

Product Science Overview

Introduction

The SARS-associated coronavirus (SARS-CoV) is a member of the Coronaviridae family, which includes a variety of viruses that can infect both animals and humans. The matrix protein (M protein) of SARS-CoV plays a crucial role in the virus’s structure and replication. Recombinant technology has enabled scientists to study this protein in detail, leading to significant advancements in our understanding of the virus.

Structure and Function of the Matrix Protein

The M protein is one of the most abundant structural proteins in SARS-CoV. It is a transmembrane protein that spans the viral envelope and interacts with other structural proteins, such as the spike (S) protein, envelope (E) protein, and nucleocapsid (N) protein. The M protein is essential for the assembly and budding of new virions, making it a key target for antiviral research.

Recombinant Technology

Recombinant technology involves the insertion of a specific gene into a host organism to produce the desired protein. In the case of SARS-CoV, the gene encoding the M protein can be inserted into bacterial, yeast, or mammalian cells, which then produce the recombinant M protein. This allows researchers to study the protein’s structure, function, and interactions in a controlled environment.

Applications of Recombinant M Protein
  1. Vaccine Development: The recombinant M protein can be used as an antigen in vaccine formulations. By stimulating an immune response against the M protein, vaccines can help protect against SARS-CoV infection.
  2. Diagnostic Tools: Recombinant M protein can be used to develop diagnostic assays for detecting SARS-CoV infections. These assays can identify antibodies against the M protein in patient samples, indicating a previous or current infection.
  3. Therapeutic Research: Understanding the interactions between the M protein and other viral or host proteins can help identify potential therapeutic targets. Inhibitors that disrupt these interactions could be developed as antiviral drugs.
Recent Advances

Recent studies have highlighted the importance of genetic recombination in the evolution of SARS-CoV and related viruses. Recombination events can lead to the emergence of new viral strains with altered properties, such as increased transmissibility or immune evasion . By studying recombinant M proteins, researchers can gain insights into these evolutionary processes and develop strategies to counteract emerging threats.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.